arrow
返回

Atherosclerosis: A Pathologist's Perspective

delete2026-02-09
delete0
delete
OA
AI
Ľ
Ľudmila Verbóová
A
Adam Nedoroščík *
T
Terézia Kisková-Šimková
A
Adriána Šmirjáková
P
P. Bohuš
M
Marek Kollár
M
Michal Virag
K
Kristína Mazarova
M
Martina Závacká
DOI:10.3390/jcdd13020085delete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
动脉粥样硬化是动脉壁的一种慢性、进行性疾病,也是缺血性心脏病、中风和周围动脉疾病等大多数心血管疾病的主要病理基础。尽管在预防、影像学和治疗方面取得了进展,但动脉粥样硬化仍然是全球心血管疾病发病率和死亡率的主要原因。从病理学角度看,该疾病代表了一个动态且异质的过程,其特征包括内皮功能障碍、脂质滞留和修饰、慢性炎症、免疫激活、平滑肌细胞表型调节、细胞外基质重塑以及血栓形成表面改变。本文从病理学家的角度对动脉粥样硬化进行了全面概述,将经典形态学概念与当代对免疫病理学、斑块分类和斑块不稳定机制的见解相结合。我们总结了动脉壁的结构和功能、病变启动和进展的逐步病理发生机制,以及由美国心脏协会建立并由Virmani框架后续完善的组织病理学分类系统。特别强调的是斑块不稳定性,突出了决定临床结局而非仅管腔狭窄的定性特征,如纤维帽变薄、坏死核心扩大、巨噬细胞驱动的炎症、斑块侵蚀和钙化模式。此外,本文讨论了免疫组织化学标志物在定义斑块生物学中的日益重要作用,包括谱系标志物和炎症、基质完整性、成骨信号传导及局部抗凝平衡的功能指标。这些病理学见解与当代风险评估工具、影像学方法、预防策略和治疗干预措施相结合,包括新兴的降脂疗法和RNA基治疗。总之,病理学在理解动脉粥样硬化作为一种生物学活跃性疾病以及完善斑块不稳定概念方面仍居核心地位。将组织病理学与分子分析、影像学和临床数据相结合,对于推进动脉粥样硬化性心血管疾病的精准预防和靶向治疗策略至关重要。
Keyword:
atherosclerosis
pathology
plaque instability
immunohistochemistry
risk assessment
prevention
therapeutic interventions

期刊

J
Journal of Cardiovascular Development and Disease
IF:
2.3
论文数:
382
被引数:
3.8K

机构

I
institute for clinical & experimental medicine (ikem)
学者数:
1.8K
论文数: 1.3K
被引数: 1
U
university of pavol jozef safarik kosice
学者数:
3.2K
论文数: 2.3K
被引数: 1
引用论文

引用论文

Transgenic Overexpression of Tissue-Nonspecific Alkaline Phosphatase (TNAP) in Vascular Endothelium Results in Generalized Arterial Calcification
err2015-12-01
err71
errOAAI
errSavinov, Alexei Y.; Salehi, Maryam; Yadav, Manisha C.; Radichev, Ilian; Millan, Jose Luis; Savinova, Olga V.
err分享
err收藏
Inclisiran for the treatment of hypercholesterolaemia
err2024-11-28
err0
PREAI
errJoel C Marrs; Sarah L Anderson
err分享
err收藏
Atherosclerosis
err2000-09-01
err0
errOAAI
errAldons J. Lusis
err分享
err收藏
Inflammatory markers in patients with internal carotid artery stenosis
err2013-01-01
err71
errOAAI
errPuz, Przemyslaw; Lasek-Bal, Anetta; Ziaja, Damian; Kazibutowska, Zofia; Ziaja, Krzysztof
err分享
err收藏
2018 ESC/ESH Guidelines for the management of arterial hypertension2018 ESC/ESH动脉高血压治疗指南
err2018-08-25
err2.6K
errOAAI
errWilliams, Bryan; Mancia, Giuseppe; Spiering, Wilko; Rosei, Enrico Agabiti; Azizi, Michel; Burnier, Michel; Clement, Denis L.; Coca, Antonio; de Simone, Giovanni; Dominiczak, Anna; Kahan, Thomas; Mahfoud, Felix; Redon, Josep; Ruilope, Luis; Zanchetti, Alberto; Kerins, Mary; Kjeldsen, Sverre E.; Kreutz, Reinhold; Laurent, Stephane; Lip, Gregory Y. H.; McManus, Richard; Narkiewicz, Krzysztof; Ruschitzka, Frank; Schmieder, Roland E.; Shlyakhto, Evgeny; Tsioufis, Costas; Aboyans, Victor; Desormais, Ileana
err分享
err收藏
COSMIC: the Catalogue Of Somatic Mutations In CancerCOSMIC: 癌症体细胞突变目录
err2018-10-29
err3.2K
errOAAI
errTate, John G.; Bamford, Sally; Jubb, Harry C.; Sondka, Zbyslaw; Beare, David M.; Bindal, Nidhi; Boutselakis, Harry; Cole, Charlotte G.; Creatore, Celestino; Dawson, Elisabeth; Fish, Peter; Harsha, Bhavana; Hathaway, Charlie; Jupe, Steve C.; Kok, Chai Yin; Noble, Kate; Ponting, Laura; Ramshaw, Christopher C.; Rye, Claire E.; Speedy, Helen E.; Stefancsik, Ray; Thompson, Sam L.; Wang, Shicai; Ward, Sari; Campbell, Peter J.; Forbes, Simon A.
err分享
err收藏
The role of the adventitia in vascular inflammation
err2007-09-01
err367
errOAAI
errMaiellaro, Kathryn; Taylor, W. Robert
err分享
err收藏
MicroRNA-26b-/- augments atherosclerosis, while mimic-loaded nanoparticles reduce atherogenesisMicroRNA-26b-/- 增强动脉粥样硬化,而 mimic 负载的纳米颗粒则抑制动脉粥样硬化形成。
err2025-11-01
err0
errOAAI
errPeters, Linsey J. F.; Bidzhekov, Kiril; Bonnin-Marquez, Andrea; Sundararaman, Sai Sahana; Huchzermeier, Rosanna; Maas, Sanne L.; Abschlag, Kathrin; Jans, Alexander; Lin, Cheng; Haberbosch, Markus; Jansen, Yvonne; Yu, Baixue; Sluimer, Judith C.; Gijbels, Marion J.; Jankowski, Joachim; Bartneck, Matthias; Biessen, Erik A. L.; Weber, Christian; Doring, Yvonne; Van Der Vorst, Emiel P. C.
err分享
err收藏
学者 查看更多内容